GlobalData on MSN3mon
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialTezspire (tezepelumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The therapy met the co-primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback